摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(邻甲苯氧基)-1-丙醇 | 52448-99-4

中文名称
3-(邻甲苯氧基)-1-丙醇
中文别名
——
英文名称
3-(o-tolyloxy)propan-1-ol
英文别名
3-o-tolyloxy-propan-1-ol;(γ-Oxy-propyl)-o-tolyl-aether;Trimethylenglykol-mono-o-tolylaether;γ-o-Kresoxy-propylalkohol;3-(2-methylphenoxy)-1-propanol;3-(o-Methylphenoxy)propylalkohol;3-(o-Tolyloxy)-1-propanol;3-(2-methylphenoxy)propan-1-ol
3-(邻甲苯氧基)-1-丙醇化学式
CAS
52448-99-4
化学式
C10H14O2
mdl
——
分子量
166.22
InChiKey
RQROCSGRAXVVFN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2909309090

SDS

SDS:371273132f59eb47ca12de888964e3a8
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Rindfusz; Ginnings; Harnack, Journal of the American Chemical Society, 1920, vol. 42, p. 163
    摘要:
    DOI:
  • 作为产物:
    描述:
    邻甲苯缩水甘油醚氢气 作用下, 以 四氢呋喃 为溶剂, 110.0 ℃ 、1.5 MPa 条件下, 生成 3-(邻甲苯氧基)-1-丙醇
    参考文献:
    名称:
    多孔金属硅酸盐材料催化末端环氧化物的区域选择性开环
    摘要:
    环氧化物还原开环是合成高附加值醇的绿色途径。在这项研究中,我们提出了一种实用的方法,通过开发多孔金属硅酸盐(PMS)催化剂,在温和条件下从脂肪族和芳香族环氧化物中高产率合成反马可夫尼科夫型醇。 PMS 材料 PMS-20 由钴和镍双金属氧化还原活性位点组成,在末端环氧化物的还原开环中表现出优异的催化活性和选择性,伯醇收率 >99%。与现有使用贵金属的方法相比,PMS-20 通过钴和镍物质之间的协同作用,表现出广泛的底物范围和优异的官能团耐受性,这通过双室电池系统表征和理论计算结果得到证实。
    DOI:
    10.1021/acs.inorgchem.3c03554
点击查看最新优质反应信息

文献信息

  • Copper(ii)-catalyzed C–O coupling of aryl bromides with aliphatic diols: synthesis of ethers, phenols, and benzo-fused cyclic ethers
    作者:Yajun Liu、Se Kyung Park、Yan Xiao、Junghyun Chae
    DOI:10.1039/c4ob00649f
    日期:——
    copper-catalyzed C–O cross-coupling reaction between aryl bromides and aliphatic diols has been developed employing a cheaper, more efficient, and easily removable copper(II) catalyst. A broad range of aryl bromides were coupled with aliphatic diols of different lengths using 5 mol% CuCl2 and 3 equivalents of K2CO3 in the absence of any other ligands or solvents to afford the corresponding hydroxyalkyl aryl ethers
    使用更便宜,更有效且易于去除的铜(II)催化剂,开发了一种高效的铜催化的芳基溴化物与脂肪族二醇之间的C-O交叉偶联反应。使用5 mol%的CuCl 2和3当量的K 2 CO 3将宽范围的芳基溴化物与不同长度的脂肪族二醇偶联在不存在任何其他配体或溶剂的情况下,以良好或优异的收率得到相应的羟烷基芳基醚。在这个新开发的方案中,脂族二醇具有多方面的功能,如偶联反应物,配体和溶剂。所得的羟烷基芳基醚进一步容易地转化成相应的苯酚,为从芳基溴化物得到的苯酚提供了一种有价值的替代方法。此外,已证明它们是用于更高级分子如苯并呋喃和苯并稠合的环醚的有用中间体。
  • Novel pyridopyprimidinone derivatives which are HM74A agonists
    申请人:Conte Aurelia
    公开号:US20070275987A1
    公开(公告)日:2007-11-29
    The invention is concerned with novel pyridopyrimidinone derivatives of formula (I): wherein R 1 to R 8 , X, Y, m and n are as defined in the description and in the claims. The compounds of the present invention are HM74A agonists with improved properties compared to niacin and can be used for the treatment and/or prevention of diseases such as dyslipidemia, atherosclerosis, diabetes, metabolic syndrome, and other related diseases associated with HM74A.
    这项发明涉及式(I)的新型吡啶吡嘧啶酮衍生物:其中R1至R8、X、Y、m和n如描述和索赔中所定义。本发明的化合物是HM74A激动剂,与烟酸相比具有改进的性能,并可用于治疗和/或预防与HM74A相关的疾病,如脂质代谢异常、动脉粥样硬化、糖尿病、代谢综合征和其他与HM74A相关的疾病。
  • METHOD FOR PRODUCING FLUORENE DERIVATIVE
    申请人:Fujii Katsuhiro
    公开号:US20120029244A1
    公开(公告)日:2012-02-02
    A method for producing a fluorene derivative by reacting fluorenone with a phenol or a phenoxyalcohol in the presence of an acid catalyst includes: adding an alkali to an obtained reaction liquid containing a fluorene derivative; and concentrating a resultant mixture liquid without removing the alkali thus added and a reaction product of the alkali, thereby separating an unreacted phenol or unreacted phenoxyalcohol.
    一种制备芴衍生物的方法,通过在酸催化剂存在下将芴酮与苯酚或苯氧乙醇反应,包括以下步骤:向含有芴衍生物的反应液中加入碱;在不去除已添加的碱和碱的反应产物的情况下浓缩混合液,从而分离未反应的苯酚或未反应的苯氧乙醇。
  • CSF-1R, Inhibitors, Compositions, and Methods of Use
    申请人:Sutton James
    公开号:US20100261679A1
    公开(公告)日:2010-10-14
    Disclosed herein are compounds and their oxides, esters, prodrugs, solvates, and pharmaceutically acceptable salts thereof, compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.
    本文公开了化合物及其氧化物、酯、前药、溶剂化物和其药学上可接受的盐,以及化合物的组合物,可以单独使用或与至少一种其他治疗剂合用,并与药学上可接受的载体一起使用,以及化合物的用途,可以单独使用或与至少一种其他治疗剂合用。这些实施例可用于抑制细胞增殖,抑制肿瘤的生长和/或代谢,治疗或预防癌症,治疗或预防类风湿性关节炎等骨骼退化性疾病,并/或抑制分子如CSF-1R。
  • COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME
    申请人:Teijin Limited
    公开号:EP3747856A1
    公开(公告)日:2020-12-09
    Provided are a novel compound having a fluorene skeleton, and a method for manufacturing the same, the compound having a low palladium content or other content of a specific metal or content of a specific compound in a raw material alcohol, and being excellent in hue or various characteristics (optical characteristics, heat resistance, moldability, and other characteristics) as a raw material or in a resin that uses the raw material. This compound is a mixture of compounds having a fluorene skeleton represented by formula (1) (in formula (1), the rings Z being (same or different) aromatic groups, R1 and R2 each independently representing a hydrogen atom, a halogen atom, or a C1-12 hydrocarbon group which may include an aromatic group, Ar1 and Ar2 representing C6-10 aromatic groups which may have a substituent, L1 and L2 representing alkylene groups, j and k each independently representing an integer of 0 or greater, and m and n each independently representing an integer of 0 to 5), the mixture of compounds having a fluorene skeleton being characterized in that the content of elemental palladium therein satisfies formula (2) ((2): 0 ≤ Pd ≤ 50 ppm), and among the mixture of compounds represented by formula (1), compounds comprising the integers m = 1-5 and n = 0 are included in a range of 0-5%.
    本发明提供了一种具有芴骨架的新型化合物及其制造方法,该化合物在原料酒精中的钯含量或其他特定金属含量或特定化合物含量较低,作为原料或在使用该原料的树脂中的色调或各种特性(光学特性、耐热性、成型性和其他特性)优良。该化合物是具有由式(1)表示的芴骨架的化合物混合物(在式(1)中,环 Z 是(相同或不同的)芳香基团,R1 和 R2 各自独立地代表氢原子、卤素原子或可包括芳香基团的 C1-12 碳氢基团,Ar1 和 Ar2 代表可具有取代基的 C6-10 芳香基团、L1和L2代表亚烷基,j和k各自独立地代表0或更大的整数,m和n各自独立地代表0至5的整数),具有芴骨架的化合物混合物的特征在于其中钯元素的含量满足式(2)((2):0≤钯≤50ppm),在式(1)表示的化合物混合物中,包含整数m=1-5和n=0的化合物在0-5%的范围内。
查看更多